Serum neurofilament light chain levels in Parkinson's Disease patients carrying the p.A53T SNCA mutation: Data from the PPMI study
Fuente:
Zenodo
Saved in:
| Main Author: | Papagiannakis, Nikolaos |
|---|---|
| Format: | Recurso digital |
| Published: |
Zenodo
2025
|
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Increased Serum Neurofilament Light Chain Levels in Parkinson's Disease Patients Carrying the p. A53T SNCA Mutation: Data from the Parkinson's Progression Markers Initiative Study
by: Nikolaos Papagiannakis, et al.
Published: (2026)
by: Nikolaos Papagiannakis, et al.
Published: (2026)
Correction to ‘Serum neurofilament light chain measurements following nerve trauma’
Published: (2024)
Published: (2024)
Comprehensive analysis of clinical and biological features in Parkinson's disease associated with the LRRK2 G2019S mutation: Data from the PPMI study
by: Xiaohui Sun, et al.
Published: (2024)
by: Xiaohui Sun, et al.
Published: (2024)
Serum neurofilament light chain and small fiber neuropathy: Every cloud has a silver lining
by: Domenico Plantone, et al.
Published: (2024)
by: Domenico Plantone, et al.
Published: (2024)
SNCA‐Related Parkinson's Disease Caused by Complete Chromosome 4 Paternal Uniparental Disomy
by: Jianyuan Zhang, et al.
Published: (2024)
by: Jianyuan Zhang, et al.
Published: (2024)
Autosomal Dominant Parkinson's Disease Caused by SNCA p.E46K Mutation in a Family with Russian Ancestry
by: Konstantin Senkevich, et al.
Published: (2024)
by: Konstantin Senkevich, et al.
Published: (2024)
Assessing Plasma APLP1 for the Progression of Parkinson's Disease: Insights from HSPD and PPMI Cohorts
by: You Ni, et al.
Published: (2025)
by: You Ni, et al.
Published: (2025)
Serum neurofilament light chain and glial fibrillary acidic protein for predicting response to apheresis in steroid‐refractory multiple sclerosis relapses
by: Ioannis Vardakas, et al.
Published: (2024)
by: Ioannis Vardakas, et al.
Published: (2024)
Multifocal motor neuropathy as a mimic of amyotrophic lateral sclerosis: Serum neurofilament light chain as a reliable diagnostic biomarker
by: Vera E. A. Kleinveld, et al.
Published: (2024)
by: Vera E. A. Kleinveld, et al.
Published: (2024)
The generalizability of proposed reference values of plasma neurofilament light chain level in Thai healthy population
by: Paramee Supaksirakol, et al.
Published: (2024)
by: Paramee Supaksirakol, et al.
Published: (2024)
From Parkinson's Progression Markers Initiative to Parkinson's Precision Medicine Initiative: Still PPMI
by: Kenneth Marek, et al.
Published: (2026)
by: Kenneth Marek, et al.
Published: (2026)
Reply to “Serum neurofilament light chain and small fiber neuropathy: Every cloud has a silver lining” by D. Plantone and G. Primiano
by: Panoraia Baka, et al.
Published: (2024)
by: Panoraia Baka, et al.
Published: (2024)
Plasma neurofilament light chain levels in chemotherapy‐induced peripheral neurotoxicity according to type of anticancer drug
by: Roser Velasco, et al.
Published: (2024)
by: Roser Velasco, et al.
Published: (2024)
Plasma neurofilament light chain, cognition, and MRI measures in community‐dwelling Hispanics
by: Raul Vintimilla, et al.
Published: (2025)
by: Raul Vintimilla, et al.
Published: (2025)
The relationship between neurofilament light chain and depressive symptoms according to cognitive status
by: Federico Bellelli, et al.
Published: (2025)
by: Federico Bellelli, et al.
Published: (2025)
Plasma neurofilament light chain in fibromyalgia: A case control study exploring correlation with clinical and cognitive features
by: Maddalena Ruggieri, et al.
Published: (2024)
by: Maddalena Ruggieri, et al.
Published: (2024)
Body composition and plasma total‐tau, neurofilament light chain, and amyloid‐β: A population‐based study
by: Tosca O. E. de Crom, et al.
Published: (2024)
by: Tosca O. E. de Crom, et al.
Published: (2024)
Expanding PPMI through Remote Data Acquisition and Analysis: Early Success and Future Growth with myPPMI
by: Caroline M. Tanner, et al.
Published: (2026)
by: Caroline M. Tanner, et al.
Published: (2026)
Longitudinal Dynamics of Physical Function With Anxiety and Depression in Parkinson's Disease: A Cross‐Lagged Panel Analysis of the PPMI Dataset
by: Philip Hodgson, et al.
Published: (2026)
by: Philip Hodgson, et al.
Published: (2026)
Cerebrospinal fluid and blood neurofilament light chain levels in amyotrophic lateral sclerosis and frontotemporal degeneration: A meta‐analysis
by: Federico Verde, et al.
Published: (2024)
by: Federico Verde, et al.
Published: (2024)
Differential relationships between plasma neurofilament light chain and various neuroimaging neurodegeneration markers
by: Dahyun Yi, et al.
Published: (2025)
by: Dahyun Yi, et al.
Published: (2025)
Association of plasma neurofilament light chain with microstructural white matter changes in Down syndrome
by: Herminia Diana Rosas, et al.
Published: (2024)
by: Herminia Diana Rosas, et al.
Published: (2024)
Association between plasma neurofilament light chain (NfL) concentrations and renal impairment
by: Susan Ashrafzadeh‐Kian, et al.
Published: (2024)
by: Susan Ashrafzadeh‐Kian, et al.
Published: (2024)
Threshold tracking transcranial magnetic stimulation and neurofilament light chain as diagnostic aids in ALS
by: Anna B. Jacobsen, et al.
Published: (2024)
by: Anna B. Jacobsen, et al.
Published: (2024)
The role of neurofilaments light chain in discriminating behavioral variant frontotemporal dementia from non‐neurodegenerative mimics
by: Chiara Gallingani, et al.
Published: (2024)
by: Chiara Gallingani, et al.
Published: (2024)
Joint effect of testosterone and neurofilament light chain on cognitive decline in men: The Shanghai Aging Study
by: Shuning Tang, et al.
Published: (2024)
by: Shuning Tang, et al.
Published: (2024)
Plasma neurofilament light chain: A novel biomarker of neuroaxonal injury associated with depressive symptoms in epilepsy
by: Zhiqing Chen, et al.
Published: (2026)
by: Zhiqing Chen, et al.
Published: (2026)
Ausencia de la mutación A53T del gen SNCA en una muestra de pacientes con Enfermedad de Parkinson en el Perú
by: Karina Milla-Neyra
Published: (2018)
by: Karina Milla-Neyra
Published: (2018)
Plasma and CSF neurofilament light chain distinguish neurodegenerative from primary psychiatric conditions in a clinical setting
by: Dhamidhu Eratne, et al.
Published: (2024)
by: Dhamidhu Eratne, et al.
Published: (2024)
A Nontransitive Theory of Truth Over pA
by: Jonathan Dittrich
Published: (2021)
by: Jonathan Dittrich
Published: (2021)
On asymptotic formula of the partition function $p_A(n)$
by: Christopher, David, et al.
Published: (2025)
by: Christopher, David, et al.
Published: (2025)
Coulomb-Nuclear Interference in polarized pA scattering
by: Kopeliovich, B. Z., et al.
Published: (2023)
by: Kopeliovich, B. Z., et al.
Published: (2023)
Characterizing the initial state of hydrodynamics in pp and pA collisions
by: Rabelo-Soares, Gabriel, et al.
Published: (2025)
by: Rabelo-Soares, Gabriel, et al.
Published: (2025)
Jet quenching for hadron-tagged jets in $pA$ collisions
by: Zakharov, B. G.
Published: (2024)
by: Zakharov, B. G.
Published: (2024)
Analysis of the LRRK2 p.G2019S mutation in Colombian Parkinson’s Disease Patients
by: Andrés Felipe Duque
Published: (2015)
by: Andrés Felipe Duque
Published: (2015)
Characterizing brain structures associated with plasma neurofilament light chain among older adults: variations by sex and APOE gene
by: Yi Dong, et al.
Published: (2024)
by: Yi Dong, et al.
Published: (2024)
Alpha‐internexin is detectable in cerebrospinal fluid – an analogue to neurofilament light?
by: Francisco J Meda, et al.
Published: (2024)
by: Francisco J Meda, et al.
Published: (2024)
Motor progression trajectories and risk of mild cognitive impairment in Parkinson's disease: A latent class trajectory model from PPMI cohort
by: Xi Chen, et al.
Published: (2024)
by: Xi Chen, et al.
Published: (2024)
Energy-Energy Correlator for jet production in $pp$ and $pA$ collisions
by: Barata, João, et al.
Published: (2024)
by: Barata, João, et al.
Published: (2024)
Small-x Physics at Coherent pA/AA Interactions at LHC
by: Victor P. Gonçalves
Published: (2007)
by: Victor P. Gonçalves
Published: (2007)
Similar Items
-
Increased Serum Neurofilament Light Chain Levels in Parkinson's Disease Patients Carrying the p. A53T SNCA Mutation: Data from the Parkinson's Progression Markers Initiative Study
by: Nikolaos Papagiannakis, et al.
Published: (2026) -
Correction to ‘Serum neurofilament light chain measurements following nerve trauma’
Published: (2024) -
Comprehensive analysis of clinical and biological features in Parkinson's disease associated with the LRRK2 G2019S mutation: Data from the PPMI study
by: Xiaohui Sun, et al.
Published: (2024) -
Serum neurofilament light chain and small fiber neuropathy: Every cloud has a silver lining
by: Domenico Plantone, et al.
Published: (2024) -
SNCA‐Related Parkinson's Disease Caused by Complete Chromosome 4 Paternal Uniparental Disomy
by: Jianyuan Zhang, et al.
Published: (2024)